334.65
-10.45
(-3.03%)
At close: January 10 at 3:30:03 PM GMT+5:30
Breakdown
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Assets
2,400,616.00
2,195,213.00
2,098,482.00
2,031,755.00
Total Liabilities Net Minority Interest
643,883.00
689,414.00
695,546.00
736,968.00
Total Equity Gross Minority Interest
1,756,733.00
1,505,799.00
1,402,936.00
1,294,787.00
Total Capitalization
1,762,912.00
1,515,972.00
1,390,864.00
1,271,287.00
Common Stock Equity
1,762,912.00
1,515,972.00
1,390,864.00
1,271,287.00
Net Tangible Assets
1,564,684.00
1,311,128.00
1,177,887.00
1,050,686.00
Working Capital
817,769.00
575,300.00
448,253.00
70,483.00
Invested Capital
2,079,377.00
1,737,907.00
1,595,182.00
1,419,325.00
Tangible Book Value
1,564,684.00
1,311,128.00
1,177,887.00
1,050,686.00
Total Debt
316,465.00
221,935.00
204,318.00
148,038.00
Net Debt
127,365.00
23,995.00
104,225.00
23,555.00
Share Issued
16,082.32
15,582.32
15,582.13
15,494.54
Ordinary Shares Number
16,082.32
15,582.32
15,582.13
15,494.54
3/31/2021 - 9/29/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MANGALAM.NS Mangalam Drugs & Organics Limited
111.36
-3.43%
BROOKS.NS Brooks Laboratories Limited
182.06
-2.00%
APLLTD.NS Alembic Pharmaceuticals Limited
1,010.05
-4.24%
ASTRAZEN.NS AstraZeneca Pharma India Limited
6,907.35
-2.56%
MEGASOFT.NS Megasoft Limited
99.10
-5.00%
JAGSNPHARM.NS Jagsonpal Pharmaceuticals Limited
213.70
-7.65%